Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-15
2006-08-15
Kwon, Brian-Yong S. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S259100, C514S234500
Reexamination Certificate
active
07091207
ABSTRACT:
A method is provided for the prevention of ischemia/reperfusion injury, for example, in patients undergoing heart surgery, and involves the administration of a phosphodiesterase-5 (PDE-5) inhibitor such as sildenafil. The method may also be used during or after a heart attack to prevent or lessen ischemic heart damage.
REFERENCES:
patent: 4337254 (1982-06-01), Moncada
patent: 6362178 (2002-03-01), Niewohner et al.
patent: WO 9920251 (1999-04-01), None
“The Role of cGMP Hydrolysing Phosphodiesterases 1 and 5 in Cerebral Artery Dilation”, Kruuse et al., Eur J Pharmacol, abstract, May 18, 2001; 420(1):55-65.
“Acute Myocardial Infarction Following Sildenafil Citrate (Viagra) intake in a Nitrate-Free Patient”, Porter et al., abstract, Clin. Cardiol., 1999, Nov. 22(11):762-3.
“Levitra: Treatment of Sexual Dysfunction”, Patient Information Brochure, 2006, www.msabout.com.
“CIALIS”, Patient Information Brochure, www.cialis.com, 2005.
“Viagra” Paitent Information Brochure, 2005, Pfizer Inc.
Hefting et al. “Role of apoptosis in reperfusion injury” Cardiovascular Research; Feb. 15, 2004 pp. 414-426.
Das et al. “Cardioprotection with slidenafil, a selective inhibitor of cyclic 3', 5′-monophosphate specific phophodiesterase 5”, Drugs under Expreimental and Clinical Research; 2002 pp. 213-219.
Ockaili et al. “Slidenafil (Viagra) Induces powerful cardioptotective effect via opening of mitochondrial KATP channels in rabbits” American Journal of Physiology (2002) pp. H1263-H1269.
Kwon Brian-Yong S.
Virginia Commonwealth University
Whitham Curtis Christofferson & Cook PC
LandOfFree
Method of treating myocardial infarction with PDE-5 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating myocardial infarction with PDE-5 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating myocardial infarction with PDE-5 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3642275